TANG CAPITAL MANAGEMENT LLC → Kezar Life Sciences, Inc. KZR

Stake: — Shares: 0 Class: Common Stock, par value $0.001 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-04-30

DTC 2.28

158,519 shares short · +4.6% vs prior

Other 13D/G Filings on Kezar Life Sciences, Inc.

Filed	Form	Filer	Stake	Shares
2025-03-03	SCHEDULE	Equal Talent Investments Ltd	8.66%	616,502	view →
2025-01-16	SCHEDULE	Morningside Venture Investments Ltd	8.45%	616,502	view →
2021-02-16	SC	Morningside Venture Investments Ltd	—	—	view →
2020-06-16	SC	Morningside Venture Investments Ltd	—	—	view →

Other Filings by TANG CAPITAL MANAGEMENT LLC

Filed	Form	Issuer	Stake	Shares
2025-09-03	SCHEDULE	iTeos Therapeutics, Inc.	100.00%	10,000	view →
2025-05-19	SCHEDULE	Allakos Inc.	100.00%	10,000	view →
2025-04-03	SCHEDULE	Allakos Inc.	9.60%	8,693,687	view →
2025-03-04	SCHEDULE	Aurinia Pharmaceuticals Inc. AUPH	7.30%	10,029,500	view →
2025-02-27	SCHEDULE	ACELYRIN, Inc.	7.30%	7,298,328	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →